Publication | Closed Access
The highs and lows of translational drug development: antibody-mediated inhibition of ADAMTS-5 for osteoarthritis disease modification
13
Citations
0
References
2014
Year
InflammationAnti-inflammatoryAutoimmune DiseaseAntibody-mediated InhibitionMedicineOsteoarthritis Disease ModificationImmunologyTranslational Drug DevelopmentOsteoarthritisPharmacologyMusculoskeletal ResearchDrug Discovery
No additional data available for this publication yet. Check back later!